(Q43786660)

26 November 2017

title

Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics (English)

1 reference

26 November 2017

1 reference

1 reference

1 reference

S Baba

1

1 reference

26 November 2017

J-MIND Study Group

series ordinal

2

1 reference

26 November 2017

language of work or name

1 reference

1 December 2001

1 reference

Diabetes Research and Clinical Practice

26 November 2017

published in

1 reference

26 November 2017

volume

54

1 reference

26 November 2017

issue

3

1 reference

26 November 2017

page(s)

191-201

1 reference

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900288-1

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900288-1

7 January 2021

Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900288-1

7 January 2021

Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900288-1

7 January 2021

Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900288-1

7 January 2021

Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900288-1

7 January 2021

Hypertension and non-insulin-dependent diabetes. A comparison between an angiotensin-converting enzyme inhibitor and a calcium antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900288-1

7 January 2021

Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900288-1

7 January 2021

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900288-1

7 January 2021

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900288-1

7 January 2021

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900288-1

7 January 2021

Microalbuminuria in diabetes mellitus: review and recommendations for the measurement of albumin in urine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900288-1

7 January 2021

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900288-1

7 January 2021

Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900288-1

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900288-1

7 January 2021

Effect of nifedipine on renal function in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900288-1

7 January 2021

The effect of nifedipine GITS on renal function in hypertensive patients with renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900288-1

7 January 2021

10.1016/S0168-8227(01)00288-1

Identifiers

DOI

1 reference

26 November 2017

1 reference